Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared on reposted from The Lancet Hematology on LinkedIn:
”Check out this podcast from The Lancet Haematology to help you plan your ASH25, we give an overview of key novelties to look out for across various sessions!”
Qutoing The Lancet Hematology‘s post:
”Are you planning to attend ASH25 in Orlando?
There’s no better way to get a sneak peek at the exciting content than hearing experts share their insights firsthand.
In our latest special episode of In Conversation With, a roundtable of leading classical and malignant haematology thought leaders — Khaled Musallam, Bethany Samuelson Bannow, Mohamad Mohty, David Sallman, and Anna Sureda Balari — preview the most anticipated ASH25 sessions and their expectations for the upcoming congress.
They discuss practical implications for clinicians, researchers, and trainees, and offer takeaways to maximise your time at the meeting.
Key areas covered:
- Thalassaemia and sickle cell disease
- Thrombosis and bleeding disorders
- Multiple myeloma
- Myeloid neoplasms
- Cellular therapies, stem-cell transplantation, and lymphoma
Tune in now; search The Lancet Haematology wherever you get your podcasts.
If you’re attending ASH25 or following from afar, please share with colleagues preparing for the meeting!
Don’t forget to hit subscribe to stay ahead with the latest in haematology!”
Find the full coverage of ASH25 in Hemostasis Today.
-
Apr 23, 2026, 18:19Chokri Ben Lamine: Choosing the Right LMWH in Cancer Patients
-
Apr 23, 2026, 17:57Shalini R: Not All Blood Thinners Are the Same
-
Apr 23, 2026, 17:33Abdulaziz (Omar) Badran: Navigating the Clinical Complexity of Combined Red Cell Disorders
-
Apr 23, 2026, 17:19Kate Thomas: One Hour, One Donation, One Life Saved
-
Apr 23, 2026, 17:19Ameneh Eshghinejad: The First 72 Hours After SAH Are Critical for Balancing the Risks of Rebleeding and Thromboembolism
-
Apr 23, 2026, 17:18Katarina Ziakova: The WFH Shared Decision – Making Tool Is Driving Critical Conversations in Haemophilia Care
-
Apr 23, 2026, 17:14Paulus Kirchhof: Can We Improve Prevention of Cardiovascular Diseases?
-
Apr 23, 2026, 17:08Wolfgang Miesbach: 5‑Year Gene Therapy Data from WFH Congress 2026
-
Apr 23, 2026, 17:05Veronica Sanchez: The 2026 Guideline on the Management of Dyslipidemia